Skip to main content

Table 4 Association of remote ischemic preconditioning and clinical end points

From: Randomized controlled trial of remote ischemic preconditioning in children having cardiac surgery

 

Control

RPC

p value

Total

(n = 39)

(N = 45)

 

(n = 84)

CICU length of stay (days)

3 [1, 8]

4 [2, 9]

0.662

4 [1, 8]

Hospital length of stay (days)

8 [5, 15]

11 [5, 22]

0.267

10 [5, 17]

In-hospital or 30-day mortality

0 (0%)

2 (4.4%)

0.183

2 (2.4%)

Preop ventricular function

    

 Normal

37 (95%)

42 (93%)

0.640

79 (94%)

 Mild dysfunction

2 (5%)

2 (4%)

 

4 (5%)

 Moderate to severe

0 (0%)

1 (2)

 

1 (1%)

Immediate post-op ventricular function in OR

    

 Normal

30 (77%)

30 (67%)

0.297

60 (71%)

 Mild dysfunction

7 (18%)

8 (18%)

 

15 (18%)

 Moderate to severe

2 (5%)

7 (16%)

 

9 (11%)

Subsequent post-op ventricular function

    

 Normal

31 (80%)

32 (71%)

0.676

63 (75%)

 Mild dysfunction

5 (13%)

8 (18%)

 

13 (16%)

 Moderate to severe

3 (8%)

5 (11%)

 

8 (10%)

Time interval of echocardiogram from preop to procedure in OR (days)

15 [10, 67]

18 [10, 74]

0.382

15 [9, 68]

Time interval of echocardiogram in the OR to discharge or closest follow-up during hospitsalization (days)

7 [4, 8]

6 [4, 8]

0.522

6 [4, 8]

Composite of dialysis, listed for heart or kidney transplant, 30-day mortality, in-hospital mortality

    

 No

39 (100%)

42 (93%)

0.101

81 (96%)

 Yes

0 (0%)

3 (7%)

 

3 (4%)